about
p53 and MDM2 in renal cell carcinoma: biomarkers for disease progression and future therapeutic targets?A systematic review of p53 as a prognostic factor of survival in squamous cell carcinoma of the four main anatomical subsites of the head and neck.Loss of MTBP expression is associated with reduced survival in a biomarker-defined subset of patients with squamous cell carcinoma of the head and neck.
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
p53: a molecular marker for the detection of cancer.
@en
p53: a molecular marker for the detection of cancer.
@nl
type
label
p53: a molecular marker for the detection of cancer.
@en
p53: a molecular marker for the detection of cancer.
@nl
prefLabel
p53: a molecular marker for the detection of cancer.
@en
p53: a molecular marker for the detection of cancer.
@nl
P2860
P1476
p53: a molecular marker for the detection of cancer
@en
P2093
Mark T Boyd
P2860
P304
P356
10.1517/17530059.2.9.1013
P407
P577
2008-09-01T00:00:00Z